Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Intagliata · SciRah

Researcher profile · Semantic Scholar

S. Intagliata

Share profile

S. Intagliata — researcher profile on SciRah

h-index: 11
Works: 27
Citations: 1,001

Most-cited papers

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
M. Garassino, J. Whisenant, Li-Ching Huang, A. Trama +45 more
2020The Lancet Oncology498 citations Open access
Semantic Scholar
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study
A. Russo, M. Russano, T. Franchina, M. Migliorino +27 more
2020Advances in Therapy150 citations
Semantic Scholar
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
D. Santini, S. Barni, S. Intagliata, A. Falcone +28 more
2015Scientific Reports129 citations Open access
Semantic Scholar
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case.
E. Roca, M. Pozzari, W. Vermi, V. Tovazzi +5 more
2019Lung Cancer50 citations
Semantic Scholar
Premetastatic niche: ready for new therapeutic interventions?
A. Zoccoli, M. Iuliani, F. Pantano, M. Imperatori +7 more
2012Expert opinion on therapeutic targets35 citations
Semantic Scholar
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases
M. Laganà, C. Gurizzan, E. Roca, D. Cortinovis +20 more
2020Frontiers in Oncology27 citations Open access
Semantic Scholar
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation
M. Russano, A. Cortellini, R. Giusti, A. Russo +46 more
2021Cancer Immunology and Immunotherapy21 citations Open access
Semantic Scholar
Physiology, Lung Dead Space
S. Intagliata, A. Rizzo, W. Gossman
201915 citations
Semantic Scholar
Recurrent scrotal hemangiomas during treatment with sunitinib.
G. Tonini, S. Intagliata, B. Cagli, F. Segreto +4 more
2010Journal of Clinical Oncology15 citations
Semantic Scholar
Role of c-mesenchymal–epithelial transition pathway in gastric cancer
I. Fioroni, Emanuela Dell'Aquila, F. Pantano, S. Intagliata +5 more
2015Expert Opinion on Pharmacotherapy14 citations
Semantic Scholar
New antiangiogenics in non-small cell lung cancer treatment: Vargatef™ (BIBF 1120) and beyond
B. Gori, S. Ricciardi, A. Fulvi, S. Intagliata +2 more
2011Therapeutics and Clinical Risk Management12 citations Open access
Semantic Scholar
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab
F. Pantano, M. Russano, A. Berruti, G. Mansueto +34 more
2020Expert Opinion on Biological Therapy11 citations Open access
Semantic Scholar
Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
D. Santini, S. Barni, S. Intagliata, A. Falcone +28 more
2016Scientific Reports9 citations Open access
Semantic Scholar
1084P PLATForM: Descriptive analysis from a randomised, phase II study of novel spartalizumab combinations in previously treated unresectable/metastatic melanoma
C. Robert, D. Schadendorf, G. Long, P. Ascierto +11 more
2021Annals of Oncology5 citations Open access
Semantic Scholar
Fixed dose rate (FDR) gemcitabine (G) and capecitabine (C) in patients with metastatic biliary tract cancer (BTC): Final results of phase II trial.
Daniele Santini, B. Vincenzi, E. Vasile, V. Catalano +6 more
2009Journal of Clinical Oncology5 citations
Semantic Scholar
Phase II capecitabine and gemcitabine fixed dose rate (FDR) in patients with advanced pancreatic cancer.
G. Tonini, B. Vincenzi, E. Vasile, V. Catalano +6 more
2009Journal of Clinical Oncology2 citations
Semantic Scholar
Phase II capecitabine and gemcitabine fixed dose rate (FDR) in patients with advanced pancreatic cancer
D. Santini, B. Vincenzi, G. Masi, V. Catalano +7 more
20082 citations
Semantic Scholar
Effect of cholesterol and triglyceride increases on time to progression in renal clear cell cancer patients treated with everolimus.
F. Pantano, G. Procopio, M. Silletta, C. Ortega +11 more
20131 citations
Semantic Scholar
Natural history of malignant bone disease in non-small cell lung cancer: Preliminary results of a multicenter bone metastasis survey.
D. Santini, S. Intagliata, T. Ibrahim, F. Ferraù +16 more
20131 citations
Semantic Scholar
The Role of Macrophages Polarization in Predicting Prognosis in Radically Resected Gastric Cancer
F. Pantano, P. Berti, F. Guida, S. Intagliata +6 more
20121 citations Open access
Semantic Scholar
Real-world description of patients with resected epidermal growth factor receptor mutation positive non-small cell lung carcinoma treated with adjuvant osimertinib in an early access program in Italy: the ELBA observational study
G. Pasello, C. Proto, C. Genova, A. Pavan +95 more
2026Frontiers in Oncology0 citations Open access
Semantic Scholar
1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic
C. Gurizzan, R. Pedersini, Carla Fornaro, C. Sardini +16 more
2020Annals of Oncology0 citations Open access
Semantic Scholar
Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice.
S. Intagliata, E. Roca, D. Cosentini, A. Berruti
2018Annals of Translational Medicine0 citations Open access
Semantic Scholar
Anatomy, Lower Limb, Knee Joint
S. Intagliata, J. Hubbard, Scott Dulebohn, S. Bhimji +1 more
20170 citations
Semantic Scholar
Targeted Therapies for Bone Metastases
D. Santini, Chiara Spoto, V. Longo, M. Iuliani +4 more
20150 citations
Semantic Scholar
Comment and reply on: Pegfilgrastim is safe and effective in the prevention of neutropenia and treatment delays in biweekly regimens
D. Santini, A. Frezza, O. Venditti, S. Intagliata +10 more
2013Expert opinion on therapeutic targets0 citations Open access
Semantic Scholar
Prognosis and chemotherapy sensitivity of metastatic biliary cancers according to primary tumor site
M. Lucchesi, S. Caponi, Daniele Santini, S. Intagliata +5 more
20100 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Tonini×16
Invite
G. Tonini — researcher profile on SciRah
D. Santini×13
Invite
D. Santini — researcher profile on SciRah
F. Pantano×11
Invite
F. Pantano — researcher profile on SciRah
B. Vincenzi×10
Invite
B. Vincenzi — researcher profile on SciRah

×6

Invite

A. Berruti — researcher profile on SciRah

Invite

A. Falcone — researcher profile on SciRah

Invite

E. Vasile — researcher profile on SciRah

Invite

V. Adamo — researcher profile on SciRah

Invite

M. Russano — researcher profile on SciRah

Invite

G. Mansueto — researcher profile on SciRah

Invite

S. Barni — researcher profile on SciRah

Invite

E. Roca — researcher profile on SciRah